Please Wait
Applying Filters...
Filters
×

filter

Jiangsu Zhongbang Pharmaceutical Co, Ltd

Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhuhai Rundu Pharmaceutical Co.,Ltd

Request an Update of Your Company Information, Events & Sales Content

CAS Number

170791-09-0

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is...

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

170791-09-0

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

170791-09-0

End Use API

Azilsartan Medoxomil

Supporting Information

View All Icon

About the Company

Established in 1997 with headquarter based in...

Established in 1997 with headquarter based in Zhuhai, China, Rundu Pharma is committed to developing, producing and marketing affordable, high quality generic drugs as well as active pharmaceutical ingredients. We boast of the complete supply chain from intermediates to APIs and to finished products, by leveraging which we stand out as a leading pharmaceutical company home and abroad. Our business is focused on delivering to patients and clients innovative products empowered by our modified release technology platform and based on the core therapeutic areas of Cardiovascular, Gastrointestinal and CNS.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

170791-09-0

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Established in 1997 with headquarter based in...

Established in 1997 with headquarter based in Zhuhai, China, Rundu Pharma is committed to developing, producing and marketing affordable, high quality generic drugs as well as active pharmaceutical ingredients. We boast of the complete supply chain from intermediates to APIs and to finished products, by leveraging which we stand out as a leading pharmaceutical company home and abroad. Our business is focused on delivering to patients and clients innovative products empowered by our modified release technology platform and based on the core therapeutic areas of Cardiovascular, Gastrointestinal and CNS.

PharmaCompass >>

First
Previous
Next
Last